Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.

Deliberative decision-making Ethics Ethics frameworks Health technology assessment Methodology National Health Insurance Priority-setting

Journal

International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113

Informations de publication

Date de publication:
08 Mar 2022
Historique:
pubmed: 9 3 2022
medline: 16 8 2022
entrez: 8 3 2022
Statut: epublish

Résumé

While ethics has been identified as a core component of health technology assessment (HTA), there are few examples of practical, systematic inclusion of ethics analysis in HTA. Some attribute the scarcity of ethics analysis in HTA to debates about appropriate methodology and the need for ethics frameworks that are relevant to local social values. The "South African Values and Ethics for Universal Health Coverage" (SAVE-UHC) project models an approach that countries can use to develop HTA ethics frameworks that are specific to their national contexts. The SAVE-UHC approach consisted of two phases. In Phase I, the research team convened and facilitated a national multistakeholder working group to develop a provisional ethics framework through a collaborative, engagement-driven process. In Phase II, the research team refined the model framework by piloting it through three simulated HTA appraisal committee meetings. Each simulated committee reviewed two case studies of sample health interventions: opioid substitution therapy and either a novel contraceptive implant or seasonal influenza immunization for children under five. The methodology was fit-for-purpose, resulting in a context-specified ethics framework and producing relevant findings to inform application of the framework for the given HTA context. The SAVE-UHC approach provides a model for developing, piloting, and refining an ethics framework for health priority-setting that is responsive to national social values. This approach also helps identify key facilitators and challenges for integrating ethics analysis into HTA processes.

Identifiants

pubmed: 35256036
doi: 10.1017/S0266462322000113
pii: S0266462322000113
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26

Subventions

Organisme : Wellcome Trust
ID : 208045/Z/17/Z
Pays : United Kingdom
Organisme : NIH HHS
ID : Visiting Scholar position at the NIH Department of
Pays : United States
Organisme : Wellcome
ID : 208045/Z/17/Z
Organisme : South African Medical Research Council
ID : 23108

Auteurs

Carleigh B Krubiner (CB)

Global Health Policy, Center for Global Development, Washington, DC, USA.
Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.

Nicola W Barsdorf (NW)

Division for Research Development, Stellenbosch University,Stellenbosch, South Africa.

Susan J Goldstein (SJ)

South African Medical Research Council (SAMRC)/Wits Centre for Health Economics and Decision Science - PRICELESS, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Atiya Mosam (A)

South African Medical Research Council (SAMRC)/Wits Centre for Health Economics and Decision Science - PRICELESS, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Sunita Potgieter (S)

Division for Research Development, Stellenbosch University,Stellenbosch, South Africa.

Michael J DiStefano (MJ)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Aviva Tugendhaft (A)

South African Medical Research Council (SAMRC)/Wits Centre for Health Economics and Decision Science - PRICELESS, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Maria W Merritt (MW)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Ryan Li (R)

Global Health and Development Group, School of Public Health, Imperial College London, London, United Kingdom.

Kalipso Chalkidou (K)

Global Health Policy, Center for Global Development, Washington, DC, USA.
Global Health and Development Group, School of Public Health, Imperial College London, London, United Kingdom.

Ruth R Faden (RR)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.

Karen J Hofman (KJ)

South African Medical Research Council (SAMRC)/Wits Centre for Health Economics and Decision Science - PRICELESS, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH